Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Cachexia × alkaloid GB18 × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cancer Cachexia (CC) 1 Cachexia 1

Interventions

testosterone enanthate 1 remune 1 olanzapine-fluoxetine combination 1 irinotecan sucrosofate 1 bermekimab 1 alkaloid GB18 1 Pentoxifylline 1 Olanzapine 1 Fluoxetine 1 Fluorouracil 1 Exercise 1 Cannabidiol 1 Adenosine Triphosphate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07519564 2026-04-09

A Phase I Clinical Study to Evaluate the PK, PD, Efficacy, and Safety of GB18 Injection in Patients With Tumor Cachexia

Kexing Biopharm Co., Ltd.

Phase 1 Not yet recruiting

Cachexia, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡